Eaton Vance Worldwide Health Sciences Fund
Eaton Vance Worldwide Health Sciences Fund reported 45 holdings worth US$758M as of May 31, 2026 (Form N-PORT)
As of May 31, 2026 · Filed Jul 27, 2026
Eaton Vance Worldwide Health Sciences Fund reported 45 holdings worth US$758M as of May 31, 2026. Largest: Eli Lilly And Company, Abbvie Inc. and Johnson & Johnson. Filed Jul 27, 2026 (Form N-PORT).
- Holdings
- 45
- Value as reported
- US$758M
The filing in full
| Company | Shares | Value as reported | % of portfolio |
|---|
| Eli Lilly And Company | 85,543 | US$94.5M | 12.5% |
| Abbvie Inc. | 225K | US$48.9M | 6.5% |
| Johnson & Johnson | 217K | US$48.9M | 6.4% |
| Astrazeneca Plc | 255K | US$47.3M | 6.2% |
| Unitedhealth Group Incorporated | 109K | US$41.6M | 5.5% |
| Roche Holding Ltd | 98,026 | US$41.2M | 5.4% |
| Merck & Company, Inc. | 324K | US$38.5M | 5.1% |
| Bristol-myers Squibb Company | 564K | US$32.2M | 4.3% |
| Vertex Pharmaceuticals Incorporated | 57,284 | US$25.6M | 3.4% |
| Gilead Sciences, Inc. | 188K | US$25.3M | 3.3% |
| Sanofi Sa | 255K | US$22.3M | 2.9% |
| Thermo Fisher Scientific Inc | 42,998 | US$21.2M | 2.8% |
| Intuitive Surgical, Inc. | 48,480 | US$20.6M | 2.7% |
| Stryker Corporation | 54,948 | US$16.8M | 2.2% |
| Boston Scientific Corporation | 341K | US$16.5M | 2.2% |
| Medtronic Plc. | 185K | US$13.7M | 1.8% |
| Lonza Group Ag | 21,010 | US$13.4M | 1.8% |
| Novo Nordisk A/s Class B | 284K | US$13M | 1.7% |
| Abbott Laboratories | 146K | US$12.5M | 1.7% |
| Novartis Ag | 83,123 | US$12.5M | 1.6% |
| Argenx Se | 14,601 | US$12.2M | 1.6% |
| Royalty Pharma Plc | 215K | US$12M | 1.6% |
| Neurocrine Biosciences, Inc. | 67,430 | US$10.7M | 1.4% |
| Mettler-toledo International, Inc. | 8,731 | US$10.3M | 1.4% |
| Straumann Holding Ag | 83,976 | US$10.1M | 1.3% |
| Quest Diagnostics Incorporated | 50,412 | US$9.83M | 1.3% |
| Genmab A/s | 34,565 | US$9.06M | 1.2% |
| Edwards Lifesciences Corporation | 103K | US$8.87M | 1.2% |
| Zoetis Inc. | 109K | US$8.5M | 1.1% |
| The Cooper Companies, Inc. | 128K | US$7.85M | 1.0% |
| Csl Limited | 99,071 | US$6.88M | 0.91% |
| Heartflow, Inc. | 219K | US$6.78M | 0.90% |
| Danaher Corporation | 37,052 | US$6.77M | 0.89% |
| Recordati S.p.a. | 91,672 | US$5.51M | 0.73% |
| Xenon Pharmaceuticals Inc. | 100K | US$5.48M | 0.72% |
| Generate Biomedicines, Inc. | 313K | US$4.1M | 0.54% |
| Apogee Therapeutics, Inc. | 33,655 | US$2.76M | 0.36% |
| Newamsterdam Pharma Company N.v. | 81,652 | US$2.75M | 0.36% |
| Caris Life Sciences, Inc. | 136K | US$2.27M | 0.30% |
| Essilorluxottica Sa | 10,648 | US$2.15M | 0.28% |
| Mbx Biosciences, Inc. | 59,688 | US$1.88M | 0.25% |
| Bio-techne Corp | 0 | US$0 | 0.00% |
| Amplifon Spa | 0 | US$0 | 0.00% |
| Mckesson Corporation | 0 | US$0 | 0.00% |
| Option Care Health, Inc. | 0 | US$0 | 0.00% |
Source
View original at SEC
Related